(Q44588486)

English

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

scientific article published in October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

sensory perception of pain

1 reference

based on heuristic

inferred from title

author name string

Alan R Gingold

1

1 reference

Europe PubMed Central

4 December 2017

Nora V Bergasa

2

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

73

1 reference

Europe PubMed Central

4 December 2017

2741-2747

1 reference

Europe PubMed Central

4 December 2017

21

1 reference

Europe PubMed Central

4 December 2017

Pathophysiology of itching

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Cholestasis in the male rat is associated with naloxone-reversible antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Cannabinoids as potential new analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

An analgesia circuit activated by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

The pruritus of cholestasis: from bile acids to opiate agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Opioid peptides and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Itching after epidural and spinal opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Experimental study of itch stimuli in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Effects of central administration of opioids on facial scratching in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900668-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0024-3205(03)00668-4

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44588486&oldid=2028787424"